Glucagon-like Peptide-1 Receptor Agonist Therapy Is Associated With Fewer Medical Complications After Carpal Tunnel Release in Diabetic Patients
GLP-1 therapy is associated with reduced risk of 90-day medical complications and hospital readmission following CTR in diabetic patients, suggesting these medications may optimize comorbidity profiles via glucose control preoperatively. Future studies may examine whether GLP-1 therapy is associated with minimum clinically important difference in patient-reported outcome measures for CTS in diabetic patients.
Authors
- Shelley S. Noland (ORCID: https://orcid.org/0000-0003-0459-1306)
- Jens T. Verhey (ORCID: https://orcid.org/0000-0001-9928-3538)
- Cullan Howlett (ORCID: https://orcid.org/0000-0002-1081-9410)
- Sara C. Kisiel
- Kevin J. Renfree (ORCID: https://orcid.org/0000-0001-7428-848X)
- Annika N. Hiredesai (ORCID: https://orcid.org/0009-0009-0043-1189)
- Krishna Unadkat (ORCID: https://orcid.org/0009-0000-6475-2832)
Institutions
- University of Arizona (US)
- Mayo Clinic in Arizona (US)
- Mayo Clinic Hospital (US)
Publication Details
- Journal
- Hand
- Published
- 2025-07-16
- DOI
- https://doi.org/10.1177/15589447251350181
- Primary Topic
- Peripheral Nerve Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00